| Announce Date | 11/12/2025 |
| EPS Normalized Actual | $0.38 (Beat by $0.06) |
| EPS GAAP Actual | $0.38 (Beat by $0.06) |
| Revenue Actual | $0.928505B |
| Revenue Surprise | Beat by $928.505M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.90183 |
| EPS GAAP Estimate | $2.90183 |
| Revenue Estimate | $0.904051701B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 3 |
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.71 | -0.43976 | 0.928505B | 9.4% | 84.46M |
| FQ2 2025 (Jun 2025) | 1.9 | -0.26283 | 0.9194B | 5.23% | 100.07M |
| FQ1 2025 (Mar 2025) | 2.79 | 0.14021 | 0.93636B | 14.11% | 129.4M |
| FQ4 2024 (Dec 2024) | 1.65 | 0.05088 | 0.849015B | 14.03% | 114.45M |
| FQ3 2024 (Sep 2024) | 0 | -1.54141 | 0.841185B | 13.99% | -762.18M |
| FQ2 2024 (Jun 2024) | 1.89 | 1.89 | 0.87134B | 18.22% | 871.34M |
| FQ1 2024 (Mar 2024) | 2.26 | 2.26 | 0.804239B | 11.72% | 804.24M |
| FQ4 2023 (Dec 2023) | 1.09 | 1.09 | 0.729866B | 19.99% | 729.87M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.90183
Consensus Revenue Estimates
0.904051701B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.44019 | -- | 3.37658 | 3.4993 | 1 |
| FQ3 2027 (Sep 2027) | 2.97937 | -- | 2.92381 | 3.01118 | 1 |
| FQ2 2027 (Jun 2027) | 3.40012 | -- | 3.33671 | 3.43642 | 1 |
| FQ1 2027 (Mar 2027) | 4.30452 | -- | 4.22492 | 4.37848 | 1 |
| FQ4 2026 (Dec 2026) | 1.97826 | -- | 1.97259 | 1.98393 | 0 |
| FQ3 2026 (Sep 2026) | 2.33271 | 26.69 | 2.32602 | 2.3394 | 0 |
| FQ2 2026 (Jun 2026) | 2.35124 | 19.19 | 2.3445 | 2.35798 | 0 |
| FQ1 2026 (Mar 2026) | 2.90183 | 3.85 | 2.89351 | 2.91015 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.27B | -- | 1.25B | 1.29B | 2 |
| FQ3 2027 (Sep 2027) | 1.25B | -- | 1.24B | 1.26B | 2 |
| FQ2 2027 (Jun 2027) | 1.26B | -- | 1.24B | 1.27B | 2 |
| FQ1 2027 (Mar 2027) | 1.27B | -- | 1.25B | 1.29B | 2 |
| FQ4 2026 (Dec 2026) | 0.94B | -- | 0.94B | 0.94B | 0 |
| FQ3 2026 (Sep 2026) | 0.94B | 0.97 | 0.94B | 0.94B | 0 |
| FQ2 2026 (Jun 2026) | 0.92B | -0.11 | 0.92B | 0.92B | 0 |
| FQ1 2026 (Mar 2026) | 0.9B | -3.57 | 0.9B | 0.91B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.14976 | 1.71 | -0.43976 | -25.72% |
| FQ2 2025 (Jun 2025) | 2.16283 | 1.9 | -0.26283 | -13.83% |
| FQ1 2025 (Mar 2025) | 2.64979 | 2.79 | 0.14021 | 5.03% |
| FQ4 2024 (Dec 2024) | 1.59912 | 1.65 | 0.05088 | 3.08% |
| FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
| FQ2 2024 (Jun 2024) | 1.89 | 1.89 | 100% | |
| FQ1 2024 (Mar 2024) | 2.26 | 2.26 | 100% | |
| FQ4 2023 (Dec 2023) | 1.09 | 1.09 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.84B | $0.93B | $84.46M | 9.1% |
| FQ2 2025 (Jun 2025) | $0.82B | $0.92B | $100.07M | 10.88% |
| FQ1 2025 (Mar 2025) | $0.81B | $0.94B | $129.4M | 13.82% |
| FQ4 2024 (Dec 2024) | $0.73B | $0.85B | $114.45M | 13.48% |
| FQ3 2024 (Sep 2024) | $1.6B | $0.84B | $-762.18M | -90.61% |
| FQ2 2024 (Jun 2024) | $0B | $0.87B | $871.34M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.8B | $804.24M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.73B | $729.87M | 100% |